Poniard's headquarters are located at 7000 Shoreline Court, Suite 270, in South San Francisco, CA., The Company also has a satellite office in Seattle, WA.
When was Poniard Pharmaceuticals founded?
Poniard Pharmaceuticals, Inc. is the successor of NeoRx Corporation, which was formed in 1984. Poniard adopted its current corporate name through a name change effective June 16, 2006.
What do I do if I hold NeoRx Corporation stock certificates?
Stock certificates of NeoRx are considered stock certificates of Poniard, and no exchange of NeoRx stock certificates is required. Securities of NeoRx Corporation by operation of law automatically became securities of Poniard at the time of the corporate name change. Although not required, shareholders wishing to exchange their NeoRx stock certificates for Poniard stock certificates can do so by contacting the Company's transfer agent. Shareholders should not destroy their NeoRx stock certificates or submit any certificates to the Company.
On what stock exchange and under what symbol is Poniard Pharmaceutical's shares traded?
Poniard Pharmaceuticals is listed on the NASDAQ stock exchange under the symbol PARD.
How many shares of Poniard Pharmaceutical common stock are outstanding?
The latest SEC Form 10-Q or 10-K lists current shares outstanding. These documents are available on this website under SEC Filings.
Does Poniard Pharmaceuticals issue dividends on its common stock?
Poniard does not pay cash dividends on its common stock and does not anticipate doing so in the foreseeable future.
What is the CUSIP number for shares of Poniard common stock?
The CUSIP number for Poniard common stock is 732 449 10 3.
What is Poniard Pharmaceutical's fiscal year end?
The fiscal year end for Poniard is December 31st.
How can I contact Poniard Pharmaceuticals regarding Investor Relations issues?
You may call Poniard at 650-745-4425 or email IR@poniard.com for assistance with Investor Relations questions.
Who are Poniard Pharmaceutical's independent auditors?
Poniard's independent auditors are KPMG, LLP.
Who is Poniard Pharmaceutical's outside legal counsel?
Poniard's legal counsel is Perkins Coie, LLP.
Who acts as transfer agent for Poniard common stock?
Mellon Investor Services LLC is the transfer agent. Mellon maintains a dedicated toll-free line for Poniard shareholders at 1-866-357-2543. Mellon's mailing address is 480 Washington Blvd., Jersey City, New Jersey 07310, Attention: Shareholder Services.
Do you have another question that hasn't been answered?
Please submit your question using the form below. Fields marked with an * are required.
